ROP:NASDAQRoper Technologies, Inc. Analysis
Data as of 2026-08-25 - not real-time
$413.37
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Roper Technologies, Inc. is priced at $413.37, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 19.2%. With RSI at 65.6 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near $381.28 and resistance around $418.75.
Multiples put this in undervalued territory: 17.2 times earnings against the sector's 34.9. Consensus targets land 7.7% above where the shares trade now. Revenue is growing at 8.5% on a 30.2% profit margin. The 0.88% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 37.9%, a beta of 0.04 and a maximum drawdown of 40.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.
Multiples put this in undervalued territory: 17.2 times earnings against the sector's 34.9. Consensus targets land 7.7% above where the shares trade now. Revenue is growing at 8.5% on a 30.2% profit margin. The 0.88% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 37.9%, a beta of 0.04 and a maximum drawdown of 40.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.
Top Market Events
SARASOTA, Fla., Aug. 06, 2026 GLOBE NEWSWIRE -- Roper Technologies, Inc. Nasdaq: ROP announced that its Board of...SARASOTA, Fla., Aug. 04, 2026 GLOBE NEWSWIRE -- Roper Technologies, Inc. Nasdaq: ROP announced that it is presenting at...SARASOTA, Fla., Aug. 04, 2026 GLOBE NEWSWIRE -- Roper Technologies, Inc. Nasdaq: ROP announced that it is presenting at...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Trading above the 200-day average of 377.26
- MACD momentum is positive
- 30-day price change of +19.2%
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 17.2 versus sector average of 34.9
- Trading above the 200-day average of 377.26
- Analyst targets imply +7.7% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 17.2 versus sector average of 34.9
- Analyst targets imply +7.7% versus the current price
- Profit margin of 30.2% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin30.24%
P/E Ratio17.2
ROE13.07%
ROA4.23%
Debt/Equity60.53
P/B Ratio2.2
Op. Cash Flow$2.7B
Free Cash Flow$2.3B
Industry P/E34.9
Technical Analysis
TrendNeutral
RSI65.6
Support$381.28
Resistance$418.75
MA 20$400.31
MA 50$370.04
MA 200$377.26
MACDBullish
VolumeDecreasing
Fear & Greed Index93.84
Valuation
Fair Value$308.76
Target Price$445.20
Upside/Downside7.70%
GradeUndervalued
TypeBlend
Dividend Yield0.88%
Risk Assessment
Beta0.04
Volatility37.90%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.